APO Research
Talk to an analyst

APO RESEARCH · REPORT

Morphine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Morphine Industry Growth and Trends Forecast to 2032

20 December 202594 pages

Choose your research edition.

Industry ResearchMorphine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Morphine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Morphine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morphine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Morphine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Morphine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Morphine include Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, Sanofi Winthrop Industrie, Purdue Pharma, Mallinckrodt Pharmaceuticals, Macfarlan Smith and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Morphine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Morphine market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Morphine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Morphine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Morphine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Morphine Market by Company

Sun Pharmaceutical Industries

Qinghai Pharmaceutical

Northeast Pharmaceutical Group

Sanofi Winthrop Industrie

Purdue Pharma

Mallinckrodt Pharmaceuticals

Macfarlan Smith

Alcaliber

Morphine Segment by Type

Injection

Oral Tablets

Capsule

Others

Morphine Segment by Application

Diarrhea Suppressant

Cough Suppressant

Anesthesia

Morphine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Oral Tablets Table 3. Major Company of Capsule Table 4. Major Company of Others Table 5. Global Morphine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Morphine Sales by Type (2021-2026) & (tons) Table 7. Global Morphine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Morphine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Morphine Sales Market Share in Value by Type (2021-2026) Table 10. Global Morphine Price by Type (2021-2026) & (US$/ton) Table 11. Global Morphine Sales by Type (2027-2032) & (tons) Table 12. Global Morphine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Morphine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Morphine Sales Market Share in Value by Type (2027-2032) Table 15. Global Morphine Price by Type (2027-2032) & (US$/ton) Table 16. North America Morphine Sales by Type (2021-2026) & (tons) Table 17. North America Morphine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Morphine Sales by Type (2021-2026) & (tons) Table 19. Europe Morphine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Morphine Sales by Type (2021-2026) & (tons) Table 21. Asia-Pacific Morphine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Morphine Sales by Type (2021-2026) & (tons) Table 23. Latin America Morphine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Morphine Sales by Type (2021-2026) & (tons) Table 25. Middle East and Africa Morphine Sales by Type (2021-2026) & (US$ Million) Table 26. Morphine Industry Trends Table 27. Morphine Industry Drivers Table 28. Morphine Industry Opportunities and Challenges Table 29. Morphine Industry Restraints Table 30. Global Morphine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Morphine Revenue Market Share by Company (2021-2026) Table 32. Global Morphine Sales by Company (2021-2026) & (tons) Table 33. Global Morphine Sales Share by Company (2021-2026) Table 34. Global Morphine Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Morphine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Morphine Major Company Production Sites and Headquarters Table 37. Global Morphine Company, Product Type & Application Table 38. Global Morphine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Morphine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Morphine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Morphine Sales by Region (2021-2026) & (tons) Table 43. Global Morphine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Morphine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Morphine Sales Market Share in Value by Region (2021-2026) Table 46. Global Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Morphine Sales by Region (2027-2032) & (tons) Table 48. Global Morphine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Morphine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Morphine Sales Market Share in Value by Region (2027-2032) Table 51. Global Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Morphine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Morphine Sales by Application (2021-2026) & (tons) Table 54. Global Morphine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Morphine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Morphine Sales Market Share in Value by Application (2021-2026) Table 57. Global Morphine Price by Application (2021-2026) & (US$/ton) Table 58. Global Morphine Sales by Application (2027-2032) & (tons) Table 59. Global Morphine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Morphine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Morphine Sales Market Share in Value by Application (2027-2032) Table 62. Global Morphine Price by Application (2027-2032) & (US$/ton) Table 63. North America Morphine Sales by Application (2021-2026) & (tons) Table 64. North America Morphine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Morphine Sales by Application (2021-2026) & (tons) Table 66. Europe Morphine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Morphine Sales by Application (2021-2026) & (tons) Table 68. Asia-Pacific Morphine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Morphine Sales by Application (2021-2026) & (tons) Table 70. Latin America Morphine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Morphine Sales by Application (2021-2026) & (tons) Table 72. Middle East and Africa Morphine Sales by Application (2021-2026) & (US$ Million) Table 73. Sun Pharmaceutical Industries Company Information Table 74. Sun Pharmaceutical Industries Business Overview Table 75. Sun Pharmaceutical Industries Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Industries Morphine Product Portfolio Table 77. Sun Pharmaceutical Industries Recent Development Table 78. Qinghai Pharmaceutical Company Information Table 79. Qinghai Pharmaceutical Business Overview Table 80. Qinghai Pharmaceutical Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Qinghai Pharmaceutical Morphine Product Portfolio Table 82. Qinghai Pharmaceutical Recent Development Table 83. Northeast Pharmaceutical Group Company Information Table 84. Northeast Pharmaceutical Group Business Overview Table 85. Northeast Pharmaceutical Group Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Northeast Pharmaceutical Group Morphine Product Portfolio Table 87. Northeast Pharmaceutical Group Recent Development Table 88. Sanofi Winthrop Industrie Company Information Table 89. Sanofi Winthrop Industrie Business Overview Table 90. Sanofi Winthrop Industrie Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Sanofi Winthrop Industrie Morphine Product Portfolio Table 92. Sanofi Winthrop Industrie Recent Development Table 93. Purdue Pharma Company Information Table 94. Purdue Pharma Business Overview Table 95. Purdue Pharma Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Purdue Pharma Morphine Product Portfolio Table 97. Purdue Pharma Recent Development Table 98. Mallinckrodt Pharmaceuticals Company Information Table 99. Mallinckrodt Pharmaceuticals Business Overview Table 100. Mallinckrodt Pharmaceuticals Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Mallinckrodt Pharmaceuticals Morphine Product Portfolio Table 102. Mallinckrodt Pharmaceuticals Recent Development Table 103. Macfarlan Smith Company Information Table 104. Macfarlan Smith Business Overview Table 105. Macfarlan Smith Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Macfarlan Smith Morphine Product Portfolio Table 107. Macfarlan Smith Recent Development Table 108. Alcaliber Company Information Table 109. Alcaliber Business Overview Table 110. Alcaliber Morphine Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Alcaliber Morphine Product Portfolio Table 112. Alcaliber Recent Development Table 113. North America Morphine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 114. North America Morphine Sales by Country (2021-2026) & (tons) Table 115. North America Morphine Sales Market Share by Country (2021-2026) Table 116. North America Morphine Sales Forecast by Country (2027-2032) & (tons) Table 117. North America Morphine Sales Market Share Forecast by Country (2027-2032) Table 118. North America Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Morphine Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Morphine Market Share by Country (2021-2026) Table 121. North America Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Morphine Market Share Forecast by Country (2027-2032) Table 123. Europe Morphine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 124. Europe Morphine Sales by Country (2021-2026) & (tons) Table 125. Europe Morphine Sales Market Share by Country (2021-2026) Table 126. Europe Morphine Sales Forecast by Country (2027-2032) & (tons) Table 127. Europe Morphine Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Morphine Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Morphine Market Share by Country (2021-2026) Table 131. Europe Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Morphine Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Morphine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Morphine Sales by Country (2021-2026) & (tons) Table 135. Asia-Pacific Morphine Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Morphine Sales Forecast by Country (2027-2032) & (tons) Table 137. Asia-Pacific Morphine Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Morphine Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Morphine Market Share by Country (2021-2026) Table 141. Asia-Pacific Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Morphine Market Share Forecast by Country (2027-2032) Table 143. Latin America Morphine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 144. Latin America Morphine Sales by Country (2021-2026) & (tons) Table 145. Latin America Morphine Sales Market Share by Country (2021-2026) Table 146. Latin America Morphine Sales Forecast by Country (2027-2032) & (tons) Table 147. Latin America Morphine Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Morphine Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Morphine Market Share by Country (2021-2026) Table 151. Latin America Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Morphine Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Morphine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Morphine Sales by Country (2021-2026) & (tons) Table 155. Middle East and Africa Morphine Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Morphine Sales Forecast by Country (2027-2032) & (tons) Table 157. Middle East and Africa Morphine Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Morphine Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Morphine Market Share by Country (2021-2026) Table 161. Middle East and Africa Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Morphine Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Morphine Distributors List Table 166. Morphine Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Morphine Image Figure 2. Global Morphine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morphine Market Size (2021-2032) & (US$ Million) Figure 4. Global Morphine Sales (2021-2032) & (tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (tons) Figure 7. Oral Tablets Image Figure 8. Global Oral Tablets Sales YoY Growth (2021-2032) & (tons) Figure 9. Capsule Image Figure 10. Global Capsule Sales YoY Growth (2021-2032) & (tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 13. Global Morphine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Morphine Market Share by Type 2025 VS 2032 Figure 15. North America Morphine Sales Market Share in Volume by Type in 2025 Figure 16. North America Morphine Sales Market Share in Value by Type in 2025 Figure 17. Europe Morphine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Morphine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Morphine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Morphine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Morphine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Morphine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Morphine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Morphine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Morphine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Diarrhea Suppressant Image Figure 28. Global Diarrhea Suppressant Sales YoY Growth (2021-2032) & (tons) Figure 29. Cough Suppressant Image Figure 30. Global Cough Suppressant Sales YoY Growth (2021-2032) & (tons) Figure 31. Anesthesia Image Figure 32. Global Anesthesia Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Morphine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Morphine Market Share by Application 2025 VS 2032 Figure 35. North America Morphine Sales Market Share in Volume by Application in 2025 Figure 36. North America Morphine Sales Market Share in Value by Application in 2025 Figure 37. Europe Morphine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Morphine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Morphine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Morphine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Morphine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Morphine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Morphine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Morphine Sales Market Share in Value by Application in 2025 Figure 45. North America Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Morphine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Morphine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Tablets
  • Capsule
  • Others
Applications
  • Diarrhea Suppressant
  • Cough Suppressant
  • Anesthesia
Companies covered
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical Group
  • Sanofi Winthrop Industrie
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Macfarlan Smith
  • Alcaliber

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Morphine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Morphine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Morphine Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Oral Tablets
  8. 1.3.3 Capsule
  9. 1.3.4 Others
  10. 1.4 Global Morphine Market Size by Type
  11. 1.4.1 Global Morphine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Morphine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Morphine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Morphine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Morphine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Morphine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Morphine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Morphine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Morphine Industry Trends
  2. 2.2 Morphine Industry Drivers
  3. 2.3 Morphine Industry Opportunities and Challenges
  4. 2.4 Morphine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Morphine Revenue (2021-2026)
  2. 3.2 Global Top Players by Morphine Sales (2021-2026)
  3. 3.3 Global Top Players by Morphine Price (2021-2026)
  4. 3.4 Global Morphine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Morphine Major Company Production Sites & Headquarters
  6. 3.6 Global Morphine Company, Product Type & Application
  7. 3.7 Global Morphine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Morphine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Morphine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Morphine Tier 1, Tier 2, and Tier 3
4 Morphine Regional Status and Outlook
  1. 4.1 Global Morphine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Morphine Historic Market Size by Region
  3. 4.2.1 Global Morphine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Morphine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Morphine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Morphine Forecasted Market Size by Region
  7. 4.3.1 Global Morphine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Morphine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Morphine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Morphine by Application
  1. 5.1 Morphine Market by Application
  2. 5.1.1 Diarrhea Suppressant
  3. 5.1.2 Cough Suppressant
  4. 5.1.3 Anesthesia
  5. 5.2 Global Morphine Market Size by Application
  6. 5.2.1 Global Morphine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Morphine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Morphine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Morphine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Morphine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Morphine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Morphine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Morphine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Morphine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Morphine Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Qinghai Pharmaceutical
  8. 6.2.1 Qinghai Pharmaceutical Company Information
  9. 6.2.2 Qinghai Pharmaceutical Business Overview
  10. 6.2.3 Qinghai Pharmaceutical Morphine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qinghai Pharmaceutical Morphine Product Portfolio
  12. 6.2.5 Qinghai Pharmaceutical Recent Developments
  13. 6.3 Northeast Pharmaceutical Group
  14. 6.3.1 Northeast Pharmaceutical Group Company Information
  15. 6.3.2 Northeast Pharmaceutical Group Business Overview
  16. 6.3.3 Northeast Pharmaceutical Group Morphine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Northeast Pharmaceutical Group Morphine Product Portfolio
  18. 6.3.5 Northeast Pharmaceutical Group Recent Developments
  19. 6.4 Sanofi Winthrop Industrie
  20. 6.4.1 Sanofi Winthrop Industrie Company Information
  21. 6.4.2 Sanofi Winthrop Industrie Business Overview
  22. 6.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
  24. 6.4.5 Sanofi Winthrop Industrie Recent Developments
  25. 6.5 Purdue Pharma
  26. 6.5.1 Purdue Pharma Company Information
  27. 6.5.2 Purdue Pharma Business Overview
  28. 6.5.3 Purdue Pharma Morphine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Purdue Pharma Morphine Product Portfolio
  30. 6.5.5 Purdue Pharma Recent Developments
  31. 6.6 Mallinckrodt Pharmaceuticals
  32. 6.6.1 Mallinckrodt Pharmaceuticals Company Information
  33. 6.6.2 Mallinckrodt Pharmaceuticals Business Overview
  34. 6.6.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
  36. 6.6.5 Mallinckrodt Pharmaceuticals Recent Developments
  37. 6.7 Macfarlan Smith
  38. 6.7.1 Macfarlan Smith Company Information
  39. 6.7.2 Macfarlan Smith Business Overview
  40. 6.7.3 Macfarlan Smith Morphine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Macfarlan Smith Morphine Product Portfolio
  42. 6.7.5 Macfarlan Smith Recent Developments
  43. 6.8 Alcaliber
  44. 6.8.1 Alcaliber Company Information
  45. 6.8.2 Alcaliber Business Overview
  46. 6.8.3 Alcaliber Morphine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Alcaliber Morphine Product Portfolio
  48. 6.8.5 Alcaliber Recent Developments
7 North America by Country
  1. 7.1 North America Morphine Sales by Country
  2. 7.1.1 North America Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Morphine Sales by Country (2021-2026)
  4. 7.1.3 North America Morphine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Morphine Market Size by Country
  6. 7.2.1 North America Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Morphine Market Size by Country (2021-2026)
  8. 7.2.3 North America Morphine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Morphine Sales by Country
  2. 8.1.1 Europe Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Morphine Sales by Country (2021-2026)
  4. 8.1.3 Europe Morphine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Morphine Market Size by Country
  6. 8.2.1 Europe Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Morphine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Morphine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Morphine Sales by Country
  2. 9.1.1 Asia-Pacific Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Morphine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Morphine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Morphine Market Size by Country
  6. 9.2.1 Asia-Pacific Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Morphine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Morphine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Morphine Sales by Country
  2. 10.1.1 South America Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Morphine Sales by Country (2021-2026)
  4. 10.1.3 South America Morphine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Morphine Market Size by Country
  6. 10.2.1 South America Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Morphine Market Size by Country (2021-2026)
  8. 10.2.3 South America Morphine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Morphine Sales by Country
  2. 11.1.1 Middle East and Africa Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Morphine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Morphine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Morphine Market Size by Country
  6. 11.2.1 Middle East and Africa Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Morphine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Morphine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Morphine Value Chain Analysis
  2. 12.1.1 Morphine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Morphine Production Mode & Process
  7. 12.2 Morphine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Morphine Distributors
  10. 12.2.3 Morphine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst